期刊文献+

2008—2009年南宁市人季节性H1N1流感病毒神经氨酸酶潜在的抗原位点和抑制剂耐药位点分析 被引量:1

Analysis of the potential antigenic site and inhibitor resistance site for neuraminidase of H1N1 influenza viruses in Nanning City,2008-2009
原文传递
导出
摘要 目的了解2008—2009年南宁市人季节性H1N1流感病毒神经氨酸酶(NA)基因的遗传进化特征,探讨NA基因潜在的抗原位点和活性位点(抑制剂耐药性位点)变异规律。方法提取2008—2009年20株H1N1流感病毒RNA,采用RT-PCR扩增病毒NA基因后进行序列测定,通过CTLPred软件预测NA基因上潜在的抗原位点,并对NA分子进化和其重要功能位点的遗传变异进行分析。结果将20株H1N1流感病毒毒株与北半球疫苗推荐株A/Solomon/3/2006和A/Bris-bane/59/2007构建进化树,NA进化树共分成3个类群,10株2008年H1N1流感病毒毒株聚集成分支Ⅱ,10株2009年毒株与疫苗株A/Brisbane/59/2007聚集成分支Ⅰ,A/Solomon/3/2006则独立形成1个分支(Ⅲ)。2008年毒株抗原位点替换频率较高,相对于A/Solomon/3/2006氨基酸替换分布在不同的3个区域的3个位点,分别是N64H、Y100H、L367I;2009年度的毒株抗原决定簇位点相对保守。在已知NA的酶活性位点中,2009年所有毒株均在275位点发生了H>Y的突变,而这种变异在2008年的毒株中未有出现。结论 A/Solomon/3/2006落后于2008年毒株,A/Brisbane/59/2007对应的疫苗在2009年能起到较好的保护作用;大量H275Y耐药株的出现提示在流感病毒监测中应密切关注其耐药位点的变异。 Objective To investigate the genetic variation and evolution characteristics of influen- za virus and understand the potential antigenic sites and active sites ( inhibitor resistance sites) of NA gene of human seasonal influenza H1 N1 viruses circulating in Nanning City during 2008 - 2009. Methods 20 samples that isolated from influenza surveillance between 2008 and 2009 were tested. RNAs were extrac- ted, and NA genes were amplified by RT-PCR and then sequenced. CTLPred software was used to predict potential antigenic sites in the NA gene. The genetic variation and important functional sites of NA genes were analyzed based on amino acid sequences. Results The NA phylogenetic tree constructed showed that the strains were divided into three branches, strains in 2008 were located in branch II , strains in 2009 with A/Brisbane/59/2007 were located in branch I , and A/Solomon/3/2006 was located in branch Ill. The substitutions of antigenic sites were relatively active in 2008. Compared to the vaccine strain A/Solomon / 3/2006, there were 3 different substitutions in antigenic sites of strains in 2008,i. e. , N64H,Y100H, and L367I,which located in 3 regions. The antigenic sites of strains in 2009 were more conserved. Among the known active sites of NA, all strains in 2009 showed mutation in site H275 changed to Y,while such muta- tion was not appeared in 2008. Conclusion A/Solomon/3/2006 lagged behind the circulating strains in2008,and the vaccine that base on A/Brisbane/59/2007 might provide a better protection for human in Nanning during 2009. Numbers of H275Y resistant strains appearing indicated that we should pay attention to the variation of resistance sites during the influenza surveillance.
出处 《华南预防医学》 2012年第5期6-10,共5页 South China Journal of Preventive Medicine
基金 广西南宁科学研究与技术开发计划项目(200802127C)
关键词 流感病毒 H1N1 神经氨酸酶 抗原位点 耐药性 Influenza virus H1 N1 Neuraminidase Antigenic site Resistance
  • 相关文献

参考文献11

  • 1GILLIAN M A, LAVER W G. The neuraminidase of influenza vires [ J ]. Structure, Function, and Genetics, 1989, 6:341 - 356 .
  • 2PRATIP S, SAMEER S C, SARAH S C. Antigenic variability in neuraminidase protein of influenza A/H3N2 vaccine strains ( 1968 -2009) [J]. Bioinformation,2011, 7(2) : 76 -81.
  • 3XAVIER D, SYLVIE V, THIERRY B, et al. Efficacy of oseha- mivir-zanamivir combination compared to each monotherapy for seasonal influenza: a randomized placebo-controlled trial [ J ]. PLoS Medicine ,2010,7 : 11.
  • 4FERRARIS O, LINA B. Mutations of neuraminidase implicated in neuraminidase inhibitors resistance [ J ]. Clin Virol, 2008,41 (1) :13 -19.
  • 5SHAILENDRA K S, NIRAJ M, RAKHI S ,et al. Structural and antigenic variance between novel izffluenza A/H1 N1/2009 and in- fluenza A/H1 N1/2008 viruses [ J ]. J Infect Dev Ctries, 2010,4 (1):1-6.
  • 6YEN H L, HOFFMANN E, TAYLOR G, et al. hnportance of neuraminidase active site residues to the neuraminidase inhibitor resistance of influenza viruses [ J ]. Journal of Virology, 2006,80 (17) :8787 -8795.
  • 7MCKIMM-BRESCHKIN J, TRIVEDI T, HAMPSON A. Neura- minidase sequence analysis and susceptibilities of influenza virus clinical isolates to zanamivir and oseltamivir [ J ].Antimicrob Agents Chemother, 2003,47 ( 7 ) :2264 - 2272.
  • 8钱方.神经氨酸酶抑制剂在对抗流感病毒中的作用[J].医药论坛杂志,2006,27(23):124-125. 被引量:4
  • 9BARANOVICH T, SAITO R , SUZUKI Y . Emergence of H274Y osehamivir-resistant A ( H1 N1 ) influenza viruses in Japan during the 2008 - 2009 season[ J]. Journal of Clinical Virology,2010,1(47) :23 -28.
  • 10苏彤,李淑华,鹿文英,韩磊,韩一芳,曹广文.一株新型甲型H1N1流感病毒H275Y的奥司他韦耐药变异分析[J].解放军医学杂志,2009,34(12):1412-1418. 被引量:10

二级参考文献26

  • 1徐红,钱渊,许航,张家淮,朱汝南,王芳.甲3型流感病毒流行株金刚烷胺耐药性的初步研究[J].中华医学杂志,2006,86(14):996-998. 被引量:6
  • 2Colman PM, Hoyne PA, Lawrence MC. Sequence and structure alignment of paramyxovirus hemagglutinin-neuraminidase with influenza virus neuraminidase. J Virol, 1993, 67(6): 2972.
  • 3Colman PM, Varghese JN, Laver WG. Structure of the catalytic and antigenic sites in influenza virus neuraminidase. Nature, 1983, 303 (5912) : 41.
  • 4Yen HL, Ilyushina NA, Salomon R, et al. Neuraminidase inhibitorresistant recombinant A/Vietnam/1203/04 (H5N1) influenza viruses retain their replication efficiency and pathogenicity in vitro and in vivo. J Virol, 2007, 81(22): 12418.
  • 5Meijer A, Laekenby A, Hungnes O, et al. Oseltamivir-resistant influenza virus A (HIN1), Europe, 2007-08 season. Emerg Infect Dis, 2009, 15(4): 552.
  • 6Mossong J, Opp M, Gerloff N, et al. Emergence of osehamivir-resistant influenza A H1N1 virus during the 2007-2008 winter season in Luxembourg: clinical characteristics and epidemiology. Antiviral Res, 2009, 84(1): 91.
  • 7Garten RJ, Davis CT, Russell CA, et al. Antigenic and genetic characteristics of swine-origin 2009 A(H1N1) influenza viruses circulating in humans. Science, 2009, 325(5937): 197.
  • 8Ferraris O, Lina B. Mutations of neuraminidase implicated in neuraminidase inhibitors resistance. J Clin Virol, 2008, 41(1) : 13.
  • 9Hurt AC, Ernest J, Deng YM, et al. Emergence and spread of oseltamivir-resistant A(H1N1) influenza viruses in Oceania, South East Asia and South Africa. Antiviral Res, 2009, 83(1): 90.
  • 10Gooskens J, Jonges M, Claas EC, et al. Morbidity and mortality associated with nosocomial transmission of oseltamivir-resistant influen za A(H1N1) virus JAMA, 2009, 301(10): 1042.

共引文献16

同被引文献15

  • 1Dawood FS, Jain S, Finelli L, et al. Emergence of a novel swine-origin influenza A(H1N1) virus in humans[J].N EnglJ Med, 2009, 360(25):2605-2615.
  • 2Fanning TG, Reid AH, Taubenberger JK. Influenza A virus neuraminidase:regions of the protein potentially in- volved in virus-host interactions[J]. Virology, 2000, 276 (2) :417-423.
  • 3Maurer-Stroh S, Ma J, Lee RT, et al. Mapping the se- quence mutations of the 2009 H1N1 influenza A virus neuraminidase relative to drug and antibody binding sites [J]. Biol Direct, 2009, 4(1 ): 18.
  • 4Morlighem JE, Aoki S, Kishima M, et al. Mutation anal- ysis of 2009 pandemic influenza A (H1N1) viruses col- lected in Japan during the peak phase of the pandemic [J]. PLoS One, 2011, 6(4) :e18956.
  • 5Ferraris O, Lina B. Mutations of neuraminidase implicat-ed in neuraminidase inhibitors resistance[J].J Clin Vi- rol, 2008, 41(1):13-19.
  • 6Ahland K, Benson MD, Costello CE, et al. Genetic mi- eroheterogeneity of human transthyretin detected by IEF [J]. Eleetrophoresis, 2007, 28(12) :2053-2064.
  • 7Liu M, Chen H, Luo F, et al. Deletion of N-glycosyla- tion sites of hepatitis C virus envelope protein E1 en- hances specific cellular and humoral immune responses [J]. Vaccine, 2007, 25(36):6572-6580.
  • 8Abe Y, Takashita E, Sugawara K, et al. Effect of the addition of oligosaccharides on the biological activities and antigenicity of influenza A/H3N2 virus hemagglu- tinin[J]. J Virol, 2004, 78(18) :9605-9611.
  • 9苏彤,李淑华,常文军,刘世建,鹿文英,韩一芳,曹广文.2009年新型甲型H1N1流感病毒神经氨酸酶基因进化分析[J].第二军医大学学报,2009,30(6):618-621. 被引量:20
  • 10苏彤,李淑华,鹿文英,韩磊,韩一芳,曹广文.一株新型甲型H1N1流感病毒H275Y的奥司他韦耐药变异分析[J].解放军医学杂志,2009,34(12):1412-1418. 被引量:10

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部